Goldman Sachs Starts Bristol-Myers Squibb Co. (BMY) at Buy
Tweet Send to a Friend
Goldman Sachs analyst Terence Flynn initiates coverage on Bristol-Myers Squibb Co. (NYSE: BMY) with a Buy rating and a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE